Seeding activity of skin misfolded tau as a biomarker for tauopathies

Abstract Background Tauopathies are a group of age-related neurodegenerative diseases characterized by the accumulation of pathologically hyperphosphorylated tau protein in the brain, leading to prion-like aggregation and propagation. They include Alzheimer’s disease (AD), progressive supranuclear p...

Full description

Saved in:
Bibliographic Details
Main Authors: Zerui Wang, Ling Wu, Maria Gerasimenko, Tricia Gilliland, Zahid Syed Ali Shah, Evalynn Lomax, Yirong Yang, Steven A. Gunzler, Vincenzo Donadio, Rocco Liguori, Bin Xu, Wen-Quan Zou
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Molecular Neurodegeneration
Subjects:
Online Access:https://doi.org/10.1186/s13024-024-00781-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846147392422805504
author Zerui Wang
Ling Wu
Maria Gerasimenko
Tricia Gilliland
Zahid Syed Ali Shah
Evalynn Lomax
Yirong Yang
Steven A. Gunzler
Vincenzo Donadio
Rocco Liguori
Bin Xu
Wen-Quan Zou
author_facet Zerui Wang
Ling Wu
Maria Gerasimenko
Tricia Gilliland
Zahid Syed Ali Shah
Evalynn Lomax
Yirong Yang
Steven A. Gunzler
Vincenzo Donadio
Rocco Liguori
Bin Xu
Wen-Quan Zou
author_sort Zerui Wang
collection DOAJ
description Abstract Background Tauopathies are a group of age-related neurodegenerative diseases characterized by the accumulation of pathologically hyperphosphorylated tau protein in the brain, leading to prion-like aggregation and propagation. They include Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and Pick’s disease (PiD). Currently, reliable diagnostic biomarkers that directly reflect the capability of propagation and spreading of misfolded tau aggregates in peripheral tissues and body fluids are lacking. Methods We utilized the seed-amplification assay (SAA) employing ultrasensitive real-time quaking-induced conversion (RT-QuIC) to assess the prion-like seeding activity of pathological tau in the skin of cadavers with neuropathologically confirmed tauopathies, including AD, PSP, CBD, and PiD, compared to normal controls. Results We found that the skin tau-SAA demonstrated a significantly higher sensitivity (75–80%) and specificity (95–100%) for detecting tauopathy, depending on the tau substrates used. Moreover, the increased tau-seeding activity was also observed in biopsy skin samples from living AD and PSP patients examined. Analysis of the end products of skin-tau SAA confirmed that the increased seeding activity was accompanied by the formation of tau aggregates with different physicochemical properties related to two different tau substrates used. Conclusions Overall, our study provides proof-of-concept that the skin tau-SAA can differentiate tauopathies from normal controls, suggesting that the seeding activity of misfolded tau in the skin could serve as a diagnostic biomarker for tauopathies.
format Article
id doaj-art-1fa0ff5660ca40fa87bdb880b0cf5a95
institution Kabale University
issn 1750-1326
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series Molecular Neurodegeneration
spelling doaj-art-1fa0ff5660ca40fa87bdb880b0cf5a952024-12-01T12:44:49ZengBMCMolecular Neurodegeneration1750-13262024-11-0119111910.1186/s13024-024-00781-1Seeding activity of skin misfolded tau as a biomarker for tauopathiesZerui Wang0Ling Wu1Maria Gerasimenko2Tricia Gilliland3Zahid Syed Ali Shah4Evalynn Lomax5Yirong Yang6Steven A. Gunzler7Vincenzo Donadio8Rocco Liguori9Bin Xu10Wen-Quan Zou11Department of Pathology, Case Western Reserve University School of MedicineBiomanufacturing Research Institute and Technology Enterprise, North Carolina Central UniversityDepartment of Pathology, Case Western Reserve University School of MedicineDepartment of Pathology, Case Western Reserve University School of MedicineDepartment of Pathology, Case Western Reserve University School of MedicineDepartment of Pathology, Case Western Reserve University School of MedicineInstitute of Neurology, Department of Neurology, Jiangxi Academy of Clinical Medical Sciences, Rare Disease Center, Key Laboratory of Rare Neurological Diseases of Jiangxi Province Health Commission, The First Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityNeurological Institute, University Hospitals Cleveland Medical CenterIRCCS Institute of Neurological Sciences of Bologna, UOC Clinica NeurologicaIRCCS Institute of Neurological Sciences of Bologna, UOC Clinica NeurologicaBiomanufacturing Research Institute and Technology Enterprise, North Carolina Central UniversityDepartment of Pathology, Case Western Reserve University School of MedicineAbstract Background Tauopathies are a group of age-related neurodegenerative diseases characterized by the accumulation of pathologically hyperphosphorylated tau protein in the brain, leading to prion-like aggregation and propagation. They include Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and Pick’s disease (PiD). Currently, reliable diagnostic biomarkers that directly reflect the capability of propagation and spreading of misfolded tau aggregates in peripheral tissues and body fluids are lacking. Methods We utilized the seed-amplification assay (SAA) employing ultrasensitive real-time quaking-induced conversion (RT-QuIC) to assess the prion-like seeding activity of pathological tau in the skin of cadavers with neuropathologically confirmed tauopathies, including AD, PSP, CBD, and PiD, compared to normal controls. Results We found that the skin tau-SAA demonstrated a significantly higher sensitivity (75–80%) and specificity (95–100%) for detecting tauopathy, depending on the tau substrates used. Moreover, the increased tau-seeding activity was also observed in biopsy skin samples from living AD and PSP patients examined. Analysis of the end products of skin-tau SAA confirmed that the increased seeding activity was accompanied by the formation of tau aggregates with different physicochemical properties related to two different tau substrates used. Conclusions Overall, our study provides proof-of-concept that the skin tau-SAA can differentiate tauopathies from normal controls, suggesting that the seeding activity of misfolded tau in the skin could serve as a diagnostic biomarker for tauopathies.https://doi.org/10.1186/s13024-024-00781-1TauopathiesAlzheimer’s diseaseSeeding activityTauReal-time quaking-induced conversion (RT-QuIC)Skin
spellingShingle Zerui Wang
Ling Wu
Maria Gerasimenko
Tricia Gilliland
Zahid Syed Ali Shah
Evalynn Lomax
Yirong Yang
Steven A. Gunzler
Vincenzo Donadio
Rocco Liguori
Bin Xu
Wen-Quan Zou
Seeding activity of skin misfolded tau as a biomarker for tauopathies
Molecular Neurodegeneration
Tauopathies
Alzheimer’s disease
Seeding activity
Tau
Real-time quaking-induced conversion (RT-QuIC)
Skin
title Seeding activity of skin misfolded tau as a biomarker for tauopathies
title_full Seeding activity of skin misfolded tau as a biomarker for tauopathies
title_fullStr Seeding activity of skin misfolded tau as a biomarker for tauopathies
title_full_unstemmed Seeding activity of skin misfolded tau as a biomarker for tauopathies
title_short Seeding activity of skin misfolded tau as a biomarker for tauopathies
title_sort seeding activity of skin misfolded tau as a biomarker for tauopathies
topic Tauopathies
Alzheimer’s disease
Seeding activity
Tau
Real-time quaking-induced conversion (RT-QuIC)
Skin
url https://doi.org/10.1186/s13024-024-00781-1
work_keys_str_mv AT zeruiwang seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies
AT lingwu seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies
AT mariagerasimenko seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies
AT triciagilliland seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies
AT zahidsyedalishah seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies
AT evalynnlomax seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies
AT yirongyang seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies
AT stevenagunzler seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies
AT vincenzodonadio seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies
AT roccoliguori seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies
AT binxu seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies
AT wenquanzou seedingactivityofskinmisfoldedtauasabiomarkerfortauopathies